Skip to main content

Table 3 Final clinico-pathological diagnosis results of the all studied nodular lesions (no. = 200)

From: Impact of lung-RADS classification system on the accurate diagnosis of pulmonary nodular lesions in oncology patients

Final lesion clinical/pathology diagnosis   No. Percent %
Group I: Benign lesions   78 39%
 a) Ground glass nodules 26/0 26 13%
 b) Pre-fissural nodules 17/0 17 8.5%
 c) Inflammatory nodules 13/0 13 6.5%
 d) Follow-up static small nodules 10/0 10 5%
 e) Fat/calcifications containing nodules 12/0 12 6%
Group II; Malignant lesions   122 61%
 a) Metastatic nodules 19/78 87 43.5%
 b) Sequamus cell carcinoma 0/19 19 9.5%
 c) Adeno-carcinoma 0/7 7 3.5%
 d) Alveolar lung cancer 0/6 6 3%
 e) Small cell carcinoma 0/3 3 1.5%
Total   200 100%